Stool Rna Testing
Stool Rna Testing - Related Videos
15:16
Detection and Genogrouping of Noroviruses from Children's Stools By Taqman One-step RT-PCR
0 Views •
Cited by 13 •
2012
A One-Step RT-PCR assay for detection and genogroup identification of Norovirus isolates from children’s stools, that utilizes primers and TaqMan probes specific to the open reading frame 1 (ORF1)-ORF2 junction region, the most conserved region of the Norovirus genome is described. A non-commercial, cost-effective RNA extraction method is detailed.
03:46
Stool Microbial DNA Isolation: Studying the Effect of Environmental Enrichment on Microbiome Diversity in Murine Tumor Model
0 Views •
2023
This video describes DNA isolation protocol from stool samples of colon tumor-bearing mice. The extracted DNA is amplified using PCR, and the product is further cleaned using a magnetic beads-based approach. This method can be used to determine the effect of environmental enrichment on colon microbiota and animal mortality.
05:07
An Enhanced Crosslinking Immunoprecipitation Method for Efficient Identification of Protein-bound RNA in Mouse Testes
0 Views •
2025
This video demonstrates the enhanced crosslinking immunoprecipitation (eCLIP) method for identifying RNA-binding proteins in mouse testis. eCLIP enables the precise identification of binding sites where RNA-binding proteins (RBPs) interact with their target RNAs.
01:30
Serum Laboratory Studies, Stool Test, Breath Test
0 Views •
2025
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
09:19
RNA Catalyst as a Reporter for Screening Drugs against RNA Editing in Trypanosomes
0 Views •
Cited by 1 •
2014
A highly sensitive ribozyme-based assay, applicable to high-throughput screening of chemicals targeting the unique process of RNA editing in trypanosomatid pathogens, is described in this paper. Inhibitors can be used as tools for hypothesis-driven analysis of the RNA editing process and ultimately as therapeutics.
FAQs
The key molecular transition is conversion of extracted RNA into complementary DNA. This DNA provides the material for downstream reverse-transcription PCR or sequencing, allowing selected transcripts to be identified and quantified. In practice, this links the original fecal biological signal to a measurable molecular result.
A stool specimen can carry RNA signals from pathogens, intestinal microbes, and host cells, so the same testing framework can address different biological questions. The target source influences interpretation: pathogen-associated signals support infection detection, microbial transcripts help characterize microbiome activity, and host-cell transcripts can contribute to studies of intestinal inflammation or neoplastic processes.
Stabilization and extraction serve different roles in the workflow. Stabilization is applied to the fecal sample before RNA is recovered, while extraction obtains the RNA used for later molecular analysis. Keeping these stages distinct helps describe what the assay actually measures: recovered transcript signals rather than an unprocessed specimen.
An appropriate workflow begins with fecal collection, followed by stabilization and RNA extraction. The recovered RNA is then converted into complementary DNA, after which reverse-transcription PCR or sequencing is used to identify and quantify selected transcripts. This sequence connects sample handling with the final molecular readout and supports analysis of pathogen, microbial, or host-cell signals.
Both methods can be used after complementary DNA conversion to identify and quantify selected transcripts. Reverse-transcription PCR provides the named PCR-based route, whereas sequencing provides a sequence-based route. The choice therefore reflects the assay design and the transcripts selected for analysis, rather than requiring a different type of fecal sample.
In medicine, stool RNA testing can complement blood- and tissue-based assessments when investigators need a noninvasive view of intestinal biology. Potential uses include supporting gastrointestinal infection detection, characterizing microbiome activity, and investigating inflammatory or neoplastic processes. It can also aid research into disease biomarkers and intestinal health, rather than serving only one clinical question.